Adjuvant therapy for HER2+ breast cancer: practice, perception, and toxicity.
Rocque G, Onitilo A, Engel J, Pettke E, Boshoven A, Kim K, Rishi S, Waack B, Wisinski KB, Tevaarwerk A, Burkard ME.
Rocque G, et al.
Breast Cancer Res Treat. 2012 Jan;131(2):713-21. doi: 10.1007/s10549-011-1862-y. Epub 2011 Nov 8.
Breast Cancer Res Treat. 2012.
PMID: 22065290
Free PMC article.